InvestorsHub Logo

RLBLB

07/23/20 5:10 AM

#1360 RE: RLBLB #1359

$PFE
PFIZER ADVANCES BATTLE AGAINST COVID-19 ON MULTIPLE FRONTS

Thursday, April 09, 2020 - 07:50am

1. Anti-viral compounds show activity against SARS-CoV-2 in preclinical screening
2. Pfizer and BioNTech enter into collaboration agreement to co-develop potential COVID-19 vaccine
3. Company shares additional data and analysis of azithromycin
4. Launch of two new studies to provide insights on the interaction between S. pneumoniae and SARS-CoV-2
5. Pfizer explores studies of JAK inhibitor tofacitinib in patients with COVID-19-related pneumonia